Channel Therapeutics Statistics Share Statistics Channel Therapeutics has n/a
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 1,745 FTD / Avg. Volume 2.83%
Short Selling Information The latest short interest is 3.88K, so 0.13% of the outstanding
shares have been sold short.
Short Interest 3.88K Short % of Shares Out 0.13% Short % of Float 0.13% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.87 and the forward
PE ratio is -12.85.
Channel Therapeutics's PEG ratio is
-0.15.
PE Ratio -0.87 Forward PE -12.85 PS Ratio 0 Forward PS 0.5 PB Ratio -2.55 P/FCF Ratio -1.2 PEG Ratio -0.15
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Channel Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.34,
with a Debt / Equity ratio of -0.81.
Current Ratio 0.34 Quick Ratio 0.34 Debt / Equity -0.81 Debt / EBITDA -0.3 Debt / FCF -0.38 Interest Coverage -9.63
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0, so Channel Therapeutics's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 25.51 200-Day Moving Average n/a Relative Strength Index (RSI) 45.19 Average Volume (20 Days) 61,710
Income Statement
Revenue n/a Gross Profit n/a Operating Income -7.57M Net Income -7.96M EBITDA -7.17M EBIT -7.17M Earnings Per Share (EPS) -13.54
Full Income Statement Balance Sheet The company has 513.44K in cash and 2.19M in
debt, giving a net cash position of -1.67M.
Cash & Cash Equivalents 513.44K Total Debt 2.19M Net Cash -1.67M Retained Earnings -21.47M Total Assets 822.85K Working Capital -6.49M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.79M
and capital expenditures 0, giving a free cash flow of -5.79M.
Operating Cash Flow -5.79M Capital Expenditures n/a Free Cash Flow -5.79M FCF Per Share -9.86
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PTHS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PTHS is $50,
which is 78.6% higher than the current price. The consensus rating is "Buy".
Price Target $50 Price Target Difference 78.6% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 2, 2025. It was a
backward
split with a ratio of 1:10.
Last Split Date Jul 2, 2025 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -87.71 Piotroski F-Score 1
